Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY 10021, USA.
World J Gastroenterol. 2013 Mar 7;19(9):1372-9. doi: 10.3748/wjg.v19.i9.1372.
Endoscopic retrograde cholangiopancreatography (ERCP) has become the preferred procedure for biliary or pancreatic drainage in various pancreatico-biliary disorders. With a success rate of more than 90%, ERCP may not achieve biliary or pancreatic drainage in cases with altered anatomy or with tumors obstructing access to the duodenum. In the past those failures were typically managed exclusively by percutaneous approaches by interventional radiologists or surgical intervention. The morbidity associated was significant especially in those patients with advanced malignancy, seeking minimally invasive interventions and improved quality of life. With the advent of biliary drainage via endoscopic ultrasound (EUS) guidance, EUS guided biliary drainage has been used more frequently within the last decade in different countries. As with any novel advanced endoscopic procedure that encompasses various approaches, advanced endoscopists all over the world have innovated and adopted diverse EUS guided biliary and pancreatic drainage techniques. This diversity has resulted in variations and improvements in EUS Guided biliary and pancreatic drainage; and over the years has led to an extensive nomenclature. The diversity of techniques, nomenclature and recent progress in our intrumentation has led to a dedicated meeting on May 7(th), 2011 during Digestive Disease Week 2011. More than 40 advanced endoscopists from United States, Brazil, Mexico, Venezuela, Colombia, Italy, France, Austria, Germany, Spain, Japan, China, South Korea and India attended this pivotal meeting. The meeting covered improved EUS guided biliary access and drainage procedures, terminology, nomenclature, training and credentialing; as well as emerging devices for EUS guided biliary drainage. This paper summarizes the meeting's agenda and the conclusions generated by the creation of this consortium group.
经内镜逆行胰胆管造影术(ERCP)已成为各种胰胆管疾病胆道或胰腺引流的首选方法。ERCP 的成功率超过 90%,但在解剖结构改变或肿瘤阻塞进入十二指肠的情况下,可能无法实现胆道或胰腺引流。在过去,这些失败通常仅由介入放射学家或外科医生通过经皮方法进行管理。相关的发病率很高,特别是对于那些寻求微创干预和提高生活质量的晚期恶性肿瘤患者。随着超声内镜(EUS)引导下胆道引流的出现,在过去十年中,EUS 引导下胆道引流在不同国家越来越多地被使用。与任何涵盖各种方法的新型先进内镜程序一样,世界各地的高级内镜医生都进行了创新并采用了不同的 EUS 引导胆道和胰腺引流技术。这种多样性导致了 EUS 引导胆道和胰腺引流的变化和改进;多年来导致了广泛的命名法。技术、命名法的多样性以及我们仪器的最新进展导致了 2011 年 5 月 7 日在 2011 年消化疾病周期间举行了一次专门会议。来自美国、巴西、墨西哥、委内瑞拉、哥伦比亚、意大利、法国、奥地利、德国、西班牙、日本、中国、韩国和印度的 40 多名高级内镜医生参加了此次重要会议。会议涵盖了改进的 EUS 引导胆道进入和引流程序、术语、命名法、培训和认证;以及用于 EUS 引导胆道引流的新兴设备。本文总结了会议的议程和该联盟小组创建所产生的结论。